A review of a landmark clinical trial that suggests the use of ESAs can improve mortality in critically ill patients.


Estimated Time to View: 30 minutes
Title: The Use of Erythropoetic-Stimulating Agents (ESAs) in Acute Illness
Author: Nirav Jasani, MD
Author Type: Fellow
Citation: Nephrology On-Demand 2012, Volume 3, Number 4
Disclaimers: None
Resource Type: Video
Recommend to a Colleague/Friend: Roll Over
Review this teaching resource: Click here



To view the interactive video, click here
To view this 720p high-definition video using an iPad or iPhone, see below

Transparent Peer Review

GD Star Rating

To learn more about our 6-point transparent peer review system, click here



More in General Nephrology (29 of 212 articles)